Skip to content 
Prevention
It is also possible to prevent cytomegalovirus, especially in immunocompromised patients. The most common drug used in these cases is ganciclovir. Other medications can be used for prevention, but most are not as effective in prophylaxis.
References
Gupta, M., & Shorman, M. (2017). Cytomegalovirus.
Azer, S. A., & Limaiem, F. (2019). Cytomegalovirus colitis.
Akpan, U. S., & Pillarisetty, L. S. (2019). Congenital cytomegalovirus infection.
Gaytant, M. A., Steegers, E. A., Semmekrot, B. A., Merkus, H. M., & Galama, J. M. (2002). Congenital cytomegalovirus infection: review of the epidemiology and outcome. Obstetrical & gynecological survey, 57(4), 245-256.
Bonalumi, S., Trapanese, A., Santamaria, A., D’Emidio, L., & Mobili, L. (2011). Cytomegalovirus infection in pregnancy: review of the literature. Journal of prenatal medicine, 5(1), 1.
Port, A. D., Orlin, A., Kiss, S., Patel, S., D’Amico, D. J., & Gupta, M. P. (2017). Cytomegalovirus retinitis: a review. Journal of Ocular Pharmacology and Therapeutics, 33(4), 224-234.Römkens, T. E., Bulte, G. J., Nissen, L. H., & Drenth, J. P. (2016). Cytomegalovirus in inflammatory bowel disease: A systematic review. World journal of gastroenterology, 22(3), 1321.
